Legend Biotech Corporation provided earnings guidance for the year ended December 31, 2021. For the year, the company expected to record a loss for the year of approximately USD 365.3 million to USD 397.4 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 USD | +1.05% | -6.43% | -32.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.09% | 7.38B | |
+14.61% | 121B | |
+17.37% | 112B | |
+3.87% | 22.57B | |
-18.35% | 20.82B | |
-15.01% | 16.3B | |
-16.61% | 16.19B | |
-42.36% | 16.17B | |
+1.61% | 13.17B | |
+23.48% | 11.11B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Corporation Provides Earnings Guidance for the Year Ended December 31, 2021